Roberts Zachary 4
4 · Allogene Therapeutics, Inc. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Roberts Zachary
EVP of R&D
Transactions
- Sale
Common Stock
2025-02-03$1.70/sh−18,832$32,014→ 643,135 total
Footnotes (1)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.